The solution structure of heparan sulfate differs from that of heparin: implications for function
- PMID: 23921391
- PMCID: PMC3784691
- DOI: 10.1074/jbc.M113.492223
The solution structure of heparan sulfate differs from that of heparin: implications for function
Abstract
The highly sulfated polysaccharides heparin and heparan sulfate (HS) play key roles in the regulation of physiological and pathophysiological processes. Despite its importance, no molecular structures of free HS have been reported up to now. By combining analytical ultracentrifugation, small angle x-ray scattering, and constrained scattering modeling recently used for heparin, we have analyzed the solution structures for eight purified HS fragments dp6-dp24 corresponding to the predominantly unsulfated GlcA-GlcNAc domains of heparan sulfate. Unlike heparin, the sedimentation coefficient s20,w of HS dp6-dp24 showed a small rotor speed dependence, where similar s20,w values of 0.82-1.26 S (absorbance optics) and 1.05-1.34 S (interference optics) were determined. The corresponding x-ray scattering measurements of HS dp6-dp24 gave radii of gyration RG values from 1.03 to 2.82 nm, cross-sectional radii of gyration RXS values from 0.31 to 0.65 nm, and maximum lengths L from 3.0 to 10.0 nm. These data showed that HS has a longer and more bent structure than heparin. Constrained scattering modeling starting from 5,000 to 12,000 conformationally randomized HS structures gave best fit dp6-dp24 molecular structures that were longer and more bent than their equivalents in heparin. Alternative fits were obtained for HS dp18 and dp24, indicating their higher bending and flexibility. We conclude that HS displays bent conformations that are significantly distinct from that for heparin. The difference is attributed to the different predominant monosaccharide sequence and reduced sulfation of HS, indicating that HS may interact differently with proteins compared with heparin.
Keywords: Analytical Ultracentrifugation; Heparan Sulfate; Heparin; Heparin-binding Protein; Molecular Modeling; X-ray Scattering.
Figures









Similar articles
-
The solution structure of heparan sulfate differs from that of heparin: implications for function.J Biol Chem. 2011 Jul 15;286(28):24842-54. doi: 10.1074/jbc.M111.226027. Epub 2011 May 16. J Biol Chem. 2011. Retraction in: J Biol Chem. 2013 Jul 19;288(29):21209. doi: 10.1074/jbc.A111.226027. PMID: 21576246 Free PMC article. Retracted.
-
Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes.J Mol Biol. 2010 Jan 22;395(3):504-21. doi: 10.1016/j.jmb.2009.10.064. Epub 2009 Nov 3. J Mol Biol. 2010. PMID: 19895822
-
Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.J Mol Biol. 2001 Jun 22;309(5):1117-38. doi: 10.1006/jmbi.2001.4720. J Mol Biol. 2001. PMID: 11399083
-
Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands.Front Immunol. 2014 Mar 31;5:126. doi: 10.3389/fimmu.2014.00126. eCollection 2014. Front Immunol. 2014. PMID: 24744754 Free PMC article. Review.
-
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.Matrix Biol. 2010 Jul;29(6):442-52. doi: 10.1016/j.matbio.2010.04.003. Epub 2010 Apr 21. Matrix Biol. 2010. PMID: 20416374 Free PMC article. Review.
Cited by
-
Structure, Dynamics, and Interactions of GPI-Anchored Human Glypican-1 with Heparan Sulfates in a Membrane.Glycobiology. 2021 Jun 3;31(5):593-602. doi: 10.1093/glycob/cwaa092. Glycobiology. 2021. PMID: 33021626 Free PMC article.
-
Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.Viruses. 2021 Dec 24;14(1):35. doi: 10.3390/v14010035. Viruses. 2021. PMID: 35062238 Free PMC article. Review.
-
Mass Spectrometry Reveals a Multifaceted Role of Glycosaminoglycan Chains in Factor Xa Inactivation by Antithrombin.Biochemistry. 2018 Aug 14;57(32):4880-4890. doi: 10.1021/acs.biochem.8b00199. Epub 2018 Jul 25. Biochemistry. 2018. PMID: 29999301 Free PMC article.
-
GAG-DB, the New Interface of the Three-Dimensional Landscape of Glycosaminoglycans.Biomolecules. 2020 Dec 11;10(12):1660. doi: 10.3390/biom10121660. Biomolecules. 2020. PMID: 33322545 Free PMC article.
-
Non-Anticoagulant Heparan Sulfate from the Ascidian Phallusia nigra Prevents Colon Carcinoma Metastasis in Mice by Disrupting Platelet-Tumor Cell Interaction.Cancers (Basel). 2020 May 26;12(6):1353. doi: 10.3390/cancers12061353. Cancers (Basel). 2020. PMID: 32466418 Free PMC article.
References
-
- Gallagher J. T., Turnbull J. E., Lyon M. (1992) Heparan sulphate proteoglycans. Molecular organisation of membrane-associated species and an approach to polysaccharide sequence analysis. Adv. Exp. Med. Biol. 313, 49–57 - PubMed
-
- Bernfield M., Kokenyesi R., Kato M., Hinkes M. T., Spring J., Gallo R. L., Lose E. J. (1992) Biology of the syndecans. A family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8, 365–393 - PubMed
-
- Conrad H. E. (1998) Heparin-binding Proteins, Academic Press, San Diego
-
- Sasisekharan R., Venkataraman G. (2000) Heparin and heparan sulfate. Biosynthesis, structure and function. Curr. Opin. Chem. Biol. 4, 626–631 - PubMed
-
- Perrimon N., Bernfield M. (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404, 725–728 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources